A number of recent veterinary case reports and research studies have demonstrated the efficacy of PEMF therapy for Legg-Calve-Perthes disease (degeneration of the head of the femur in the hip socket), allowing one dog to avoid surgery (6), better and longer post-therapeutic reduction in pain than NSAID therapy for osteoarthritis (7), reduced incision-site pain, lower concentrations of spinal cord inflammatory biomarkers, and improved proprioceptive function in dogs who had surgery for intervertebral disc extrusion (8), as well as reduced need for pain relief and improved wound scores post-operatively (9). A huge number of other studies have been published with research on cell lines and laboratory animal models, raising the potential for PEMF therapy to improve outcomes in cancer patients, both in combination with other therapies and alone (10, 11, 12). The known vasodilation and anti-inflammatory benefits also raise the consideration for use in behavioural disorders, such as anxiety and depression, and neurological conditions affecting the brain, such as stroke or traumatic brain injury (3).